Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
After finishing at $0.81 in the prior trading day, Seres Therapeutics Inc (NASDAQ: MCRB) closed at $0.82, up 1.06%. In other words, the price has increased by $1.06 from its previous closing price. On the day, 1.16 million shares were traded. MCRB stock price reached its highest trading level at $0.89 during the session, while it also had its lowest trading level at $0.81.
Ratios:
Our goal is to gain a better understanding of MCRB by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.12 and its Current Ratio is at 1.12. In the meantime, Its Debt-to-Equity ratio is 3.91 whereas as Long-Term Debt/Eq ratio is at 3.56.
On April 21, 2023, JP Morgan started tracking the stock assigning a Neutral rating and target price of $7.JP Morgan initiated its Neutral rating on April 21, 2023, with a $7 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Nov 18 ’24 when DesRosier Thomas sold 878 shares for $0.54 per share. The transaction valued at 475 led to the insider holds 135,192 shares of the business.
von Moltke Lisa sold 977 shares of MCRB for $528 on Nov 18 ’24. The insider now owns 32,415 shares after completing the transaction at $0.54 per share. On Nov 18 ’24, another insider, Shaff Eric D., who serves as the CEO and President of the company, sold 2,505 shares for $0.54 each. As a result, the insider received 1,355 and left with 170,389 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, MCRB now has a Market Capitalization of 140568592 and an Enterprise Value of 137967632. For the stock, the TTM Price-to-Sale (P/S) ratio is 2367.56 while its Price-to-Book (P/B) ratio in mrq is 5.86. Its current Enterprise Value per Revenue stands at 1.092 whereas that against EBITDA is -3.78.
Stock Price History:
Over the past 52 weeks, MCRB has reached a high of $2.05, while it has fallen to a 52-week low of $0.54. The 50-Day Moving Average of the stock is 4.02%, while the 200-Day Moving Average is calculated to be -7.56%.
Shares Statistics:
The stock has traded on average 4.07M shares per day over the past 3-months and 2533740 shares per day over the last 10 days, according to various share statistics. A total of 170.20M shares are outstanding, with a floating share count of 124.67M. Insiders hold about 26.98% of the company’s shares, while institutions hold 23.58% stake in the company. Shares short for MCRB as of 1731628800 were 16235306 with a Short Ratio of 3.99, compared to 1728950400 on 18054013. Therefore, it implies a Short% of Shares Outstanding of 16235306 and a Short% of Float of 12.73.
